Cargando…
Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells
Cetuximab is widely used in patients with metastatic colon cancer expressing wildtype KRAS. However, acquired drug resistance limits its clinical efficacy. Exosomes are nanosized vesicles secreted by various cell types. Tumor cell-derived exosomes participate in many biological processes, including...
Autores principales: | Zhang, S., Zhang, Y., Qu, J., Che, X., Fan, Y., Hou, K., Guo, T., Deng, G., Song, N., Li, C., Wan, X., Qu, X., Liu, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685060/ https://www.ncbi.nlm.nih.gov/pubmed/29160412 http://dx.doi.org/10.1590/1414-431X20176472 |
Ejemplares similares
-
B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways
por: Xia, F, et al.
Publicado: (2017) -
miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma
por: Liu, Y, et al.
Publicado: (2016) -
Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma
por: Wang, H, et al.
Publicado: (2014) -
USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma
por: Qu, Zhi, et al.
Publicado: (2019) -
BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
por: Li, X, et al.
Publicado: (2013)